These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22122184)

  • 41. Dabigatran etexilate: an oral direct thrombin inhibitor for the management of thromboembolic disorders.
    Cheng JW; Vu H
    Clin Ther; 2012 Apr; 34(4):766-87. PubMed ID: 22444784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Namibia becomes first country in Africa to launch dabigatran etexilate for atrial fibrillation.
    Wagenaar P
    Cardiovasc J Afr; 2011; 22(5):283. PubMed ID: 21983957
    [No Abstract]   [Full Text] [Related]  

  • 43. Dabigatran etexilate, a thrombin inhibitor for the prevention of venous thromboembolism and stroke.
    Ieko M
    Curr Opin Investig Drugs; 2007 Sep; 8(9):758-68. PubMed ID: 17729188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dabigatran etexilate: a new thrombin inhibitor.
    Verma AK
    Med J Aust; 2010 Apr; 192(7):407-12. PubMed ID: 20367591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dabigatran etexilate in venous thromboembolism.
    Ferrer E
    Drugs Today (Barc); 2009 Oct; 45(10):715-24. PubMed ID: 20069135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dabigatran: will it change clinical practice?
    Wartak SA; Bartholomew JR
    Cleve Clin J Med; 2011 Oct; 78(10):657-64. PubMed ID: 21968472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate.
    Wienen W; Stassen JM; Priepke H; Ries UJ; Hauel N
    Thromb Haemost; 2007 Jul; 98(1):155-62. PubMed ID: 17598008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coadministration of dabigatran etexilate and atorvastatin: assessment of potential impact on pharmacokinetics and pharmacodynamics.
    Stangier J; Rathgen K; Stähle H; Reseski K; Körnicke T; Roth W
    Am J Cardiovasc Drugs; 2009; 9(1):59-68. PubMed ID: 19178132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bleeding with dabigatran (Pradaxa).
    Med Lett Drugs Ther; 2011 Dec; 53(1379-1380):98. PubMed ID: 22173427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of dabigatran in elderly patients.
    Legrand M; Mateo J; Aribaud A; Ginisty S; Eftekhari P; Huy PT; Drouet L; Payen D
    Arch Intern Med; 2011 Jul; 171(14):1285-6. PubMed ID: 21788545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis.
    Wolowacz SE; Roskell NS; Plumb JM; Caprini JA; Eriksson BI
    Thromb Haemost; 2009 Jan; 101(1):77-85. PubMed ID: 19132192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapy.
    Avecilla ST; Ferrell C; Chandler WL; Reyes M
    Am J Clin Pathol; 2012 Apr; 137(4):572-4. PubMed ID: 22431533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S; Ansell J
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
    Garcia DA
    Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa).
    Cardiovasc J Afr; 2010; 21(3):173-4. PubMed ID: 20532462
    [No Abstract]   [Full Text] [Related]  

  • 56. Dabigatran: a new anticoagulant for stroke prevention in patients with atrial fibrillation.
    Weachter R
    Mo Med; 2012; 109(2):146-9. PubMed ID: 22675797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New oral anticoagulants in the ED setting: a review.
    Pollack CV
    Am J Emerg Med; 2012 Nov; 30(9):2046-54. PubMed ID: 22795419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dabigatran versus warfarin for patients with non-valvular atrial fibrillation: is the patient the winner?
    Grave S
    Aust Nurs J; 2011 Dec-2012 Jan; 19(6):30-3. PubMed ID: 22329103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.
    Eriksson BI; Friedman RJ
    Clin Appl Thromb Hemost; 2009; 15 Suppl 1():25S-31S. PubMed ID: 19648146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Should dabigatran replace warfarin for stroke prevention in AF?
    Drug Ther Bull; 2011 Oct; 49(10):114-7. PubMed ID: 21994438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.